Chemours Reports Slight Increase in Net Sales but Wider Net Loss in Q1 2026

The Chemours Company reported a slight increase in net sales for the first quarter of 2026, reaching $1.381 billion compared to $1.368 billion in the same period of 2025. However, the company experienced a net loss of $29 million, or $0.19 per share, compared to a loss of $5 million, or $0.03 per share, in the prior year. The increase in sales was primarily driven by a 2% rise in prices, which offset a 4% decline in volume, attributed mainly to challenges in the Advanced Performance Materials segment. The cost of goods sold also rose by 3% to $1.169 billion, largely due to higher raw material costs.

Chemours undertook several strategic initiatives during the quarter, including the issuance of $700 million in senior unsecured notes due in 2034, which were used to redeem portions of existing debt. The company also completed the sale of nine parcels of land in Taiwan for approximately $287 million, with a gain expected to be recognized in the second quarter of 2026. Additionally, Chemours initiated a restructuring program aimed at improving operational efficiency, resulting in $13 million in restructuring charges, a significant decrease from $33 million in the same quarter of the previous year.

Operationally, Chemours reported a 12% increase in accounts receivable, totaling $759 million, reflecting higher sales in the Thermal & Specialized Solutions segment. However, inventories decreased by 2% to $1.536 billion, indicating a reduction in raw materials and finished goods. The company’s current liabilities also saw a decline, dropping to $1.609 billion from $1.686 billion, primarily due to lower accounts payable.

Looking ahead, Chemours maintains a positive outlook, expecting to generate additional cash flows from operations in 2026. The company believes it has sufficient liquidity to meet its obligations through at least May 2027, supported by $563 million in cash and cash equivalents and $953 million available under its revolving credit facility. However, ongoing legal and environmental matters, particularly related to PFAS liabilities, continue to pose risks that could impact future financial performance. The company is actively engaged in discussions with regulatory authorities and stakeholders to address these challenges while pursuing its strategic goals.